Candida albicans forms biofilms on the vaginal mucosa

Microbiology

Volumn 156, Issue 12, 2010, Pages 3635-3644

  Harriott, M M ^a   Lilly, E A ^b   Rodriguez, T E ^b   Fidel Jr , P L ^b,c   Noverr, M C ^b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCR1 PROTEIN; EFG1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EX VIVO STUDY; EXTRACELLULAR MATRIX; FEMALE; FUNGAL COLONIZATION; FUNGAL STRAIN; IN VIVO STUDY; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VAGINA EPITHELIUM; VAGINA MUCOSA; VAGINITIS; WILD TYPE;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; DIOXYGENASES; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; VAGINA;

CANDIDA; CANDIDA ALBICANS; FUNGI; MURINAE;

EID: 78650061313     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.039354-0     Document Type: Article

References (36)

1. Baillie, G. S. & Douglas, L. J. (2000). Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46, 397-403.
2. Barousse, M. M., Steele, C., Dunlap, K., Espinosa, T., Boikov, D., Sobel, J. D. & Fidel, P. L., Jr (2001). Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis 184, 1489-1493.
3. Barousse, M. M., Espinosa, T., Dunlap, K. & Fidel, P. L., Jr (2005). Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis. Infect Immun 73, 7765-7767.
4. Bauters, T. G., Dhont, M. A., Temmerman, M. I. & Nelis, H. J. (2002). Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol 187, 569-574.
5. Blankenship, J. R. & Mitchell, A. P. (2006). How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9, 588-594.
6. Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T. & Ghannoum, M. A. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183, 5385-5394.
7. Crump, J. A. & Collignon, P. J. (2000). Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 19, 1-8.
8. Davis, D., Edwards, J. E., Jr, Mitchell, A. P. & Ibrahim, A. S. (2000). Candida albicans RIM101 pH response pathway is required for hostpathogen interactions. Infect Immun 68, 5953-5959.
9. Dominic, R. M., Shenoy, S. & Baliga, S. (2007). Candida biofilms in medical devices: evolving trends. Kathmandu Univ Med J (KUMJ) 5, 431-436. (Pubitemid 351500371)
10. Dongari-Bagtzoglou, A., Kashleva, H., Dwivedi, P., Diaz, P. & Vasilakos, J. (2009). Characterization of mucosal Candida albicans biofilms. PLoS ONE 4, e7967.
11. Fidel, P. L., Jr, Barousse, M., Espinosa, T., Ficarra, M., Sturtevant, J., Martin, D. H., Quayle, A. J. & Dunlap, K. (2004). An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 72, 2939-2946. (Pubitemid 38542424)
12. Hawser, S. P. & Douglas, L. J. (1994). Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62, 915-921. (Pubitemid 24065575)
13. Kojic, E. M. & Darouiche, R. O. (2004). Candida infections of medical devices. Clin Microbiol Rev 17, 255-267.
14. Lo, H. J., Kohler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. & Fink, G. R. (1997). Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939-949. (Pubitemid 27381632)
15. Mathema, B., Cross, E., Dun, E. & other authors (2001). Prevalence of vaginal colonization by drug-resistant Candida species in collegeage women with previous exposure to over-the-counter azole antifungals. Clin Infect Dis 33, E23-E27.
16. Naglik, J. R., Fidel, P. L., Jr & Odds, F. C. (2008). Animal models of mucosal Candida infection. FEMS Microbiol Lett 283, 129-139. (Pubitemid 351678571)
17. Nett, J., Lincoln, L., Marchillo, K. & Andes, D. (2007a). Beta-1,3-glucan as a test for central venous catheter biofilm infection. J Infect Dis 195, 1705-1712.
18. Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M. & Andes, D. (2007b). Putative role of beta-1,3-glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51, 510-520.
19. NIH (1999). SBIR/STTR study and control of microbial biofilms. http://grants.nih.gov/grants/guide/pa-files/PA-99-084.html
20. Nobile, C. J. & Mitchell, A. P. (2005). Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15, 1150-1155.
21. Nobile, C. J., Andes, D. R., Nett, J. E., Smith, F. J., Yue, F., Phan, Q. T., Edwards, J. E., Filler, S. G. & Mitchell, A. P. (2006a). Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2, e63.
22. Nobile, C. J., Nett, J. E., Andes, D. R. & Mitchell, A. P. (2006b). Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 5, 1604-1610. (Pubitemid 44622591)
23. Norice, C. T., Smith, F. J., Jr, Solis, N., Filler, S. G. & Mitchell, A. P. (2007). Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot Cell 6, 2046-2055. (Pubitemid 350221273)
24. Owen, D. H. & Katz, D. F. (1999). A vaginal fluid simulant. Contraception 59, 91-95.
25. Ramage, G., Vandewalle, K., Wickes, B. L. & Lopez-Ribot, J. L. (2001). Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18, 163-170. (Pubitemid 34116636)
26. Ramage, G., VandeWalle, K., Lopez-Ribot, J. L. & Wickes, B. L. (2002). The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214, 95-100. (Pubitemid 35245528)
27. Ramage, G., Martinez, J. P. & Lopez-Ribot, J. L. (2006). Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6, 979-986. (Pubitemid 44568854)
28. Scott, T. G., Curran, B. & Smyth, C. J. (1989). Electron microscopy of adhesive interactions between Gardnerella vaginalis and vaginal epithelial cells, McCoy cells and human red blood cells. J Gen Microbiol 135, 475-480. (Pubitemid 19091456)
29. Slutsky, B., Buffo, J. & Soll, D. R. (1985). High frequency switching of colony morphology in Candida albicans. Science 230, 666-669.
30. Sobel, J. D. (1992). Pathogenesis and treatment of recurrent vulvovagnial candidiasis. Clin Infect Dis 14, S148-S153.
31. Sobel, J. D., Faro, S., Foxman, B., Ledge, W. J., Nyirjesy, P. R., Reed, B. D. & Summers, P. R. (1998). Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 178, 203-211. (Pubitemid 28124116)
32. Stoldt, V. R., Sonneborn, A., Leuker, C. E. & Ernst, J. F. (1997). Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16, 1982-1991.
33. Swidsinski, A., Mendling, W., Loening-Baucke, V., Swidsinski, S., Dorffel, Y., Scholze, J., Lochs, H. & Verstraelen, H. (2008). An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 198, 97.
34. Taylor, B. N., Fichtenbaum, C., Saavedra, M., Slavinsky, I. J., Swoboda, R., Wozniak, K., Arribas, A., Powderly, W. & Fidel, P. L., Jr (2000). In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J Infect Dis 182, 955-959.
35. van der Meijden, W. I., Koerten, H., van Mourik, W. & de Bruijn, W. C. (1988). Descriptive light and electron microscopy of normal and cluecell- positive discharge. Gynecol Obstet Invest 25, 47-57.
36. Watamoto, T., Samaranayake, L. P., Jayatilake, J. A., Egusa, H., Yatani, H. & Seneviratne, C. J. (2009). Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Int J Antimicrob Agents 34, 333-339.